Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-30

FDA Approved: DESONIDE OINTMENT, 0.05% — Original Application (Encube Ethicals, Inc.)

View source ↗

Summary

FDA approved Desonide Ointment 0.05% as a generic topical corticosteroid for relief of inflammatory and pruritic skin conditions; indicated for corticosteroid-r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desonide Ointment, 0.05% (desonide)

Snippet

ORIG AP for DESONIDE OINTMENT, 0.05% (DESONIDE OINTMENT, 0.05%)